NCT01443676View on ClinicalTrials.gov

Avastin Plus Radiotherapy in Elderly Patients With Glioblastoma

PHASE2CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2016

Conditions
Glioblastoma
Interventions
DRUG

Bevacizumab

Bevacizumab will be added to radiotherapy

RADIATION

Radiation therapy

Radiation therapy

Trial Locations (1)

Unknown

Department of Neurology, University Hospital Zurich, Zurich

All Listed Sponsors
lead

University of Zurich

OTHER

NCT01443676 - Avastin Plus Radiotherapy in Elderly Patients With Glioblastoma | Biotech Hunter | Biotech Hunter